NanoRepro AG
XETRA:NN6

Watchlist Manager
NanoRepro AG Logo
NanoRepro AG
XETRA:NN6
Watchlist
Price: 1.53 EUR -2.55% Market Closed
Market Cap: €19.7m

NanoRepro AG
PP&E Gross

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

NanoRepro AG
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
NanoRepro AG
XETRA:NN6
PP&E Gross
€348.7k
CAGR 3-Years
N/A
CAGR 5-Years
190%
CAGR 10-Years
N/A
Carl Zeiss Meditec AG
XETRA:AFX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Siemens Healthineers AG
XETRA:SHL
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sartorius AG
XETRA:SRT
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

NanoRepro AG
Glance View

Market Cap
19.7m EUR
Industry
Health Care

NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 17 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.

NN6 Intrinsic Value
1.96 EUR
Undervaluation 22%
Intrinsic Value
Price €1.53

See Also

What is NanoRepro AG's PP&E Gross?
PP&E Gross
348.7k EUR

Based on the financial report for Jun 30, 2025, NanoRepro AG's PP&E Gross amounts to 348.7k EUR.

What is NanoRepro AG's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
190%

Over the last year, the PP&E Gross growth was 326%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett